JD Health International valuation
$32.60Change from previous close: +0.56%Absolute change: +$0.18
Valuation
The P/E ratio is 15.0. The average price target of 16 analysts is $64.11.
Data as of November 22, 2026
JD Health International compared with similar companies
JD Health International's P/E (trailing 12 months): 15.0, −34% against the median of a group of 10 similar companies (22.8).
| Metric | JD Health International | Median | 25th–75th percentile | Band |
|---|---|---|---|---|
| P/E (trailing 12 months) | 15.0 | 22.8 | 18.2 – 32.3 | Low |
| Forward P/E | 11.3 | 21.6 | 13.0 – 40.3 | Low |
| EV/EBITDA | 10.8 | 17.2 | 11.9 – 52.8 | Low |
| Price/book | 1.43 | 3.82 | 2.98 – 7.10 | Low |
| Price/sales | 1.32 | 1.32 | 0.81 – 2.85 | Middle |
| Gross margin | 25.3% | 27.1% | 22.7% – 44.5% | Middle |
| Operating margin | 6.1% | 6.1% | 4.8% – 9.1% | Middle |
| Net margin | 7.9% | 5.7% | 2.6% – 8.0% | Middle |
| ROE | 10.4% | 19.7% | 10.9% – 20.7% | Low |
| Debt/equity | 0.01 | 0.55 | 0.12 – 0.96 | Low |
Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.
TickerLandia analysisHow it is calculated
Companies in the group: same and related industries, similar size
Other metrics
Valuation multiples
- Market cap
- $103.98B
- Enterprise value
- $55.19B
- PEG
- 2.18
- EV/revenue
- 0.70
Profitability and growth
- ROA
- 3.7%
- ROIC
- 5.0%
- Revenue growth (year over year)
- 15.9%
- Earnings growth (year over year)
- 32.1%
Financial health
- Total cash
- $49.27B
- Total debt
- $874.85M
- Current ratio
- 2.69
- Quick ratio
- 2.33
- Altman Z-Score
- 5.73
- Piotroski F-Score
- 6.00
Dividends
- Dividend yield
- 0.0%
- Payout ratio
- 0.0%
Analysts and estimates
- Average price target
- $64.11
- Median price target
- $62.44
- High price target
- $96.18
- Low price target
- $44.88
- Analysts with a price target
- 16
- Consensus
- Strong buy
- Forward EPS
- $2.90
- EPS estimate, current year
- $2.11
Shares and trading
- Beta
- 1.22
- Average volume
- 10.08M
- Shares outstanding
- 3.19B
- Float
- 1.01B
- Institutional ownership
- 17.0%
- Insider ownership
- 68.2%
